SCHEMBL7583880

SCHEMBL7583880

CC1C(NC(=O)c2ccc(-c3ccnc(F)c3)[nH]2)C2CCN1CC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
TAS1R2 Q8TE23 1/20 0.39
CHRNB2 P17787 9/20 0.35
CHRNA4 P43681 9/20 0.35
CHRNA7 P36544 7/20 0.35
GSK3B P49841 2/20 0.34
PREP P48147 1/20 0.33
FAP Q12884 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2A1 P68400 1/20 0.33
MAPK14 Q16539 1/20 0.33
PTPN1 P18031 1/20 0.33
PTPN11 Q06124 1/20 0.33
BRAF P15056 1/20 0.32
TLR9 Q9NR96 2/20 0.32
TLR8 Q9NR97 2/20 0.32
TLR7 Q9NYK1 2/20 0.32
CSNK1D P48730 1/20 0.32
CSNK1E P49674 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7218955 1.00 TAS1R3 (0.39) TAS1R3TAS1R1TAS1R2CHRNB2CHRNA4
SCHEMBL7124514 0.87 ACKR3 (0.37) TAS1R3TAS1R1TAS1R2CHRNB2CHRNA4
SCHEMBL7223878 0.86 CHRNA7 (0.42) CHRNB2CHRNA4CHRNA7PTPN1
SCHEMBL7128777 0.85 PTPN1 (0.35) CHRNB2CHRNA4CHRNA7PTPN1PTPN11
SCHEMBL7582167 0.85 PTPN1 (0.35) CHRNB2CHRNA4CHRNA7PTPN1PTPN11
SCHEMBL7225519 0.85 PTPN1 (0.38) CHRNB2CHRNA4CHRNA7PTPN1PTPN11
SCHEMBL7119650 0.84 CHRNB2 (0.39) TAS1R3TAS1R1TAS1R2CHRNB2CHRNA4
SCHEMBL7590680 0.84 CHRNB2 (0.40) CHRNB2CHRNA4CHRNA7PTPN1PTPN11
SCHEMBL7121913 0.84 CHRNB2 (0.40) CHRNB2CHRNA4CHRNA7PTPN1PTPN11
SCHEMBL7117126 0.83 PTPN1 (0.49) CHRNB2CHRNA4CHRNA7PTPN1PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002015662-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO disclosed